Cargando…
Extended-spectrum β-lactamases in Gram Negative Bacteria
Extended-spectrum β-lactamases (ESBLs) are a group of plasmid-mediated, diverse, complex and rapidly evolving enzymes that are posing a major therapeutic challenge today in the treatment of hospitalized and community-based patients. Infections due to ESBL producers range from uncomplicated urinary t...
Autores principales: | Rawat, Deepti, Nair, Deepthi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946684/ https://www.ncbi.nlm.nih.gov/pubmed/20927289 http://dx.doi.org/10.4103/0974-777X.68531 |
Ejemplares similares
-
Quinolone and Cephalosporin Resistance in Enteric Fever
por: Capoor, Malini Rajinder, et al.
Publicado: (2010) -
Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients
por: Loomba, Poonam Sood, et al.
Publicado: (2010) -
Cephalosporin Resistance in Neisseria gonorrhoeae
por: Bala, Manju, et al.
Publicado: (2010) -
Multidrug Resistant Acinetobacter
por: Manchanda, Vikas, et al.
Publicado: (2010) -
SG-APSIC1073: Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis
por: Ling, Weiping, et al.
Publicado: (2023)